1. Home
  2. TSAT vs TECX Comparison

TSAT vs TECX Comparison

Compare TSAT & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Telesat Corporation

TSAT

Telesat Corporation

HOLD

Current Price

$40.30

Market Cap

697.5M

Sector

Industrials

ML Signal

HOLD

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$21.82

Market Cap

618.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
TSAT
TECX
Founded
1969
2019
Country
Canada
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
697.5M
618.9M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
TSAT
TECX
Price
$40.30
$21.82
Analyst Decision
Buy
Strong Buy
Analyst Count
5
10
Target Price
$65.70
★ $71.00
AVG Volume (30 Days)
98.6K
★ 217.1K
Earning Date
11-03-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 40.70
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$23.01
$15.60
52 Week High
$61.54
$39.53

Technical Indicators

Market Signals
Indicator
TSAT
TECX
Relative Strength Index (RSI) 48.53 28.64
Support Level $44.96 $20.52
Resistance Level $46.56 $23.61
Average True Range (ATR) 2.10 1.10
MACD -0.14 0.07
Stochastic Oscillator 47.98 10.59

Price Performance

Historical Comparison
TSAT
TECX

About TSAT Telesat Corporation

Telesat Corp is a satellite operator, that provides its customers with mission-critical communications services. It operates in a single operating segment, in which it provides satellite-based services to its broadcast, enterprise, and consulting customers around the world. The company has two operating segments: GEO services (GEO) segment that refers to the operation of the fleet of GEO satellite and LEO services (LEO) segment that refers to the deployment and operation of the Telesat Lightspeed constellation Geographically, it derives a majority of its revenue from Canada. It derives revenue from Broadcast, Enterprise, Consulting, and others.

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Share on Social Networks: